Shares of Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 55 ($0.68) and traded as high as GBX 56 ($0.69). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.68), with a volume of 70,791 shares.
Verona Pharma plc (VRP.L) Trading Up 5.8 %
The firm has a market capitalization of £228.00 million and a price-to-earnings ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The business has a fifty day moving average price of GBX 55 and a 200 day moving average price of GBX 55.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Featured Stories
- Five stocks we like better than Verona Pharma plc (VRP.L)
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Stocks Leading the U.S. Agriculture Comeback
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Calculate Return on Investment (ROI)
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.